These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 14597212)
1. B lymphocytes from individuals with common variable immunodeficiency respond to B lymphocyte stimulator (BLyS protein) in vitro. Stewart DM; McAvoy MJ; Hilbert DM; Nelson DL Clin Immunol; 2003 Nov; 109(2):137-43. PubMed ID: 14597212 [TBL] [Abstract][Full Text] [Related]
2. BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. Moore PA; Belvedere O; Orr A; Pieri K; LaFleur DW; Feng P; Soppet D; Charters M; Gentz R; Parmelee D; Li Y; Galperina O; Giri J; Roschke V; Nardelli B; Carrell J; Sosnovtseva S; Greenfield W; Ruben SM; Olsen HS; Fikes J; Hilbert DM Science; 1999 Jul; 285(5425):260-3. PubMed ID: 10398604 [TBL] [Abstract][Full Text] [Related]
3. B lymphocyte stimulator (BLyS): a therapeutic trichotomy for the treatment of B lymphocyte diseases. Nardelli B; Moore PA; Li Y; Hilbert DM Leuk Lymphoma; 2002 Jul; 43(7):1367-73. PubMed ID: 12389615 [TBL] [Abstract][Full Text] [Related]
5. [The immunopotentiation of human B lymphocyte stimulator C-terminal peptide]. Tian RY; Han W; Yu Y; Chen Y; Yu GS; Yang SL; Gong Y Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Dec; 35(12):1128-32. PubMed ID: 14673506 [TBL] [Abstract][Full Text] [Related]
6. BLyS and BLyS receptor expression in non-Hodgkin's lymphoma. Briones J; Timmerman JM; Hilbert DM; Levy R Exp Hematol; 2002 Feb; 30(2):135-41. PubMed ID: 11823048 [TBL] [Abstract][Full Text] [Related]
7. To B or not to B: TNF family signaling in lymphocytes. Siegel RM; Lenardo MJ Nat Immunol; 2001 Jul; 2(7):577-8. PubMed ID: 11429537 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and immunological effects of exogenously administered recombinant human B lymphocyte stimulator (BLyS) in mice. Parry TJ; Riccobene TA; Strawn SJ; Williams R; Daoud R; Carrell J; Sosnovtseva S; Miceli RC; Poortman CM; Sekut L; Li Y; Fikes J; Sung C J Pharmacol Exp Ther; 2001 Feb; 296(2):396-404. PubMed ID: 11160623 [TBL] [Abstract][Full Text] [Related]
9. Mutational analysis of human BLyS in patients with common variable immunodeficiency. Losi CG; Salzer U; Gatta R; Lougaris V; Cattaneo G; Meini A; Soresina A; Grimbacher B; Plebani A J Clin Immunol; 2006 Jul; 26(4):396-9. PubMed ID: 16838132 [TBL] [Abstract][Full Text] [Related]
10. Construction and direct immunization of eukaryotic expression plasmid encoding human soluble B lymphocyte stimulator. Chen G; Du H; Peng S; Xu D; Wang J Front Biosci; 2006 Jan; 11():121-5. PubMed ID: 16146718 [TBL] [Abstract][Full Text] [Related]
11. Mechanism of BLyS action in B cell immunity. Do RK; Chen-Kiang S Cytokine Growth Factor Rev; 2002 Feb; 13(1):19-25. PubMed ID: 11750877 [TBL] [Abstract][Full Text] [Related]
12. Identification of a receptor for BLyS demonstrates a crucial role in humoral immunity. Yan M; Marsters SA; Grewal IS; Wang H; Ashkenazi A; Dixit VM Nat Immunol; 2000 Jul; 1(1):37-41. PubMed ID: 10881172 [TBL] [Abstract][Full Text] [Related]
13. B-lymphocyte stimulator (BLyS) stimulates immunoglobulin production and malignant B-cell growth in Waldenstrom macroglobulinemia. Elsawa SF; Novak AJ; Grote DM; Ziesmer SC; Witzig TE; Kyle RA; Dillon SR; Harder B; Gross JA; Ansell SM Blood; 2006 Apr; 107(7):2882-8. PubMed ID: 16304043 [TBL] [Abstract][Full Text] [Related]
14. Construction and function of two Cys146-mutants with high activity, derived from recombinant human soluble B lymphocyte stimulator. Chen G; Peng S; Zou M; Xu H; Xu D; Wang J J Biochem; 2004 Jul; 136(1):73-9. PubMed ID: 15269242 [TBL] [Abstract][Full Text] [Related]
15. Rapid and specific targeting of 125I-labeled B lymphocyte stimulator to lymphoid tissues and B cell tumors in mice. Riccobene TA; Miceli RC; Lincoln C; Knight Y; Meadows J; Stabin MG; Sung C J Nucl Med; 2003 Mar; 44(3):422-33. PubMed ID: 12621010 [TBL] [Abstract][Full Text] [Related]
16. A role for BLyS in the activation of innate immune cells. Chang SK; Arendt BK; Darce JR; Wu X; Jelinek DF Blood; 2006 Oct; 108(8):2687-94. PubMed ID: 16825497 [TBL] [Abstract][Full Text] [Related]
17. Human B lymphocyte malignancies: exploitation of BLyS and APRIL and their receptors. Jelinek DF; Darce JR Curr Dir Autoimmun; 2005; 8():266-88. PubMed ID: 15564725 [TBL] [Abstract][Full Text] [Related]
18. B lymphocyte stimulator activates p38 mitogen-activated protein kinase in human Ig class switch recombination. Yamada T; Zhang K; Yamada A; Zhu D; Saxon A Am J Respir Cell Mol Biol; 2005 May; 32(5):388-94. PubMed ID: 15668322 [TBL] [Abstract][Full Text] [Related]
19. Generation and characterization of LymphoStat-B, a human monoclonal antibody that antagonizes the bioactivities of B lymphocyte stimulator. Baker KP; Edwards BM; Main SH; Choi GH; Wager RE; Halpern WG; Lappin PB; Riccobene T; Abramian D; Sekut L; Sturm B; Poortman C; Minter RR; Dobson CL; Williams E; Carmen S; Smith R; Roschke V; Hilbert DM; Vaughan TJ; Albert VR Arthritis Rheum; 2003 Nov; 48(11):3253-65. PubMed ID: 14613291 [TBL] [Abstract][Full Text] [Related]
20. Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune response. Do RK; Hatada E; Lee H; Tourigny MR; Hilbert D; Chen-Kiang S J Exp Med; 2000 Oct; 192(7):953-64. PubMed ID: 11015437 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]